Authors:
GURMAN G
KOC H
AKAN H
ILHAN O
OZCAN M
ARSLAN O
SUNGUROGLU A
KONUK N
BEKSAC M
UYSAL A
Citation: G. Gurman et al., DONOR MONONUCLEAR-CELLS INFUSION AND ALFA INTERFERON ADMINISTRATION IN RELAPSED CHRONIC MYELOID-LEUKEMIA PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 3800-3800
Authors:
ILHAN O
OZCAN M
BEKSAC M
KOC H
AKAN H
KUTLAY S
DALVA K
GURMAN G
ARSLAN O
ARAT M
DILEK I
KONUK N
UYSAL A
Citation: O. Ilhan et al., THE PROGNOSTIC RELEVANCE OF HLA PHENOTYPE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN TURKISH PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 88(10), 1996, pp. 3825-3825
Authors:
BEKSAC M
ARAT M
OZCAN M
ARSLAN O
KOC H
AKAN H
ILHAN O
GURMAN G
KONUK N
UYSAL A
Citation: M. Beksac et al., COMPARISON OF PERIPHERAL-BLOOD, LYMPH-NODE AND BONE-MARROW LYMPHOCYTESURFACE-ANTIGENS, ADHESION MOLECULES IN B-CLL AND LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 88(10), 1996, pp. 958-958
Authors:
GURMAN G
KAHVECI G
AKAN H
ILHAN O
KOC H
BEKSAC M
KONUK N
UYSAL A
Citation: G. Gurman et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS A 2ND TRANSPLANT FOR SEVERE APLASTIC-ANEMIA, Bone marrow transplantation, 15(3), 1995, pp. 485-486
Authors:
ILHAN O
BEKSAC M
KOC H
AKAN H
KESKIN A
ARSLAN O
GURMAN G
OCAN M
KONUK N
UYSAL A
Citation: O. Ilhan et al., HLA-DR FREQUENCY IN TURKISH APLASTIC-ANEMIA PATIENTS AND THE IMPACT OF HLA-DR2 POSITIVITY IN RESPONSE RATE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY, Blood, 86(5), 1995, pp. 2055-2056
Authors:
ILHAN O
BEKSAC M
KOC H
AKAN H
KESKIN A
ARSLAN O
GURMAN G
OCAN M
KONUK N
UYSAL A
Citation: O. Ilhan et al., HLA-DR FREQUENCY IN TURKISH APLASTIC-ANEMIA PATIENTS AND THE IMPACT OF HLA-DR2 POSITIVITY IN RESPONSE RATE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY, Blood, 86(5), 1995, pp. 2055-2055
Authors:
KOC H
AKAN H
ILHAN O
GURMAN G
OZCAN M
ARSLAN O
BEKSAC M
KONUK N
UYSAL A
Citation: H. Koc et al., RELATIONSHIP BETWEEN SERUM CYTOKINE LEVELS AND APLASIA PERIOD FOLLOWING HIGH-DOSE CHEMOTHERAPY SUPPORTED BY GRANULOCYTE-COLONY-STIMULATING FACTOR AS A SALVAGE CHEMOTHERAPY WITHOUT STEM-CELL RESCUE IN MALIGNANT-LYMPHOMAS, Blood, 86(10), 1995, pp. 2779-2779
Authors:
ILHAN O
ARSLAN O
KOC H
BEKSAC M
AKAN H
GURMAN G
OZCAN M
KONUK N
UYSAL A
Citation: O. Ilhan et al., HIGH-DOSE EPIRUBICIN CONTAINING CEOP REGIMEN IN INTERMEDIATE OR HIGH-GRADE NONHODGKINS LYMPHOMA, Blood, 86(10), 1995, pp. 3245-3245
Authors:
ARSLAN O
AKAN H
BEKSAC M
ILHAN O
KOC H
KONUK N
Citation: O. Arslan et al., TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) POSITIVITY IN ACUTE NONLYMPHOBLASTIC LEUKEMIA, Leukemia, 8(6), 1994, pp. 1067-1067